LEBEL FRANCOIS 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Mar 16, 2022
Insider Transaction Report
Form 4
LEBEL FRANCOIS
Chief Medical Officer
Transactions
- Sale
Common Stock, $0.001 par value
2022-03-15$0.70/sh−25,130$17,717→ 280,190 total - Sale
Common Stock, $0.001 par value
2022-03-16$0.71/sh−25,105$17,724→ 255,085 total
Holdings
- 7,226(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (1)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.